Part B Drug Payment Change: Understanding the Implications for Pharma
By Jennifer Snow, MPH |
Jennifer Snow recorded a live webinar on March 28, 2016 and provided insights on the Part B Drug Payment Model. She focused on what’s known about the proposed Medicare Part B drug payment model and what the implications are for pharmaceutical manufacturers. Ms. Snow also shared strategies on how manufacturers will have to evolve to demonstrate product value.
Topics:
Policy
Legislation